Here, we performed an integrative pan-cancer analysis across 53 independent datasets spanning 33 tumour types, incorporating transcriptomic (<i>YBX1</i> mRNA), proteomic (RPPA), genomic, and clinical data. The gene discussed is YBX1; the disease is neoplasm.